News + Filings Holdings
|
BVF INC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
MoonLake Immunotherapeutics
| MLTX | Common | 21,751,284 | 0 | 1,109,315,484,000 | 880,927,002,000 | 30.92 | 41.27 |
Hist
| 06/30/2023 |
Revolution Medicines, Inc.
| RVMD | Common | 6,255,588 | 3,000,000 | 167,336,979,000 | 89,788,873,000 | 4.66 | 5.88 |
Hist
| 06/30/2023 |
Axsome Therapeutics, Inc.
| AXSM | COM | 2,131,100 | 376,100 | 153,140,846,000 | 17,777,696,000 | 4.27 | |
Hist
| 06/30/2023 |
IDEAYA Biosciences, Inc.
| IDYA | Common | 5,683,489 | 3,478,400 | 133,561,992,000 | 93,495,525,000 | 3.72 | 11.75 |
Hist
| 06/30/2023 |
IONIS PHARMACEUTICALS INC
| IONS | Common | 2,846,015 | 1,724,206 | 116,771,995,000 | 74,401,269,000 | 3.25 | 1.99 |
Hist
| 06/30/2023 |
GH Research PLC
| GHRS | Common | 9,275,158 | 0 | 110,049,750,000 | 20,358,972,000 | 3.07 | 17.83 |
Hist
| 06/30/2023 |
Kymera Therapeutics, Inc.
| KYMR | Common | 4,739,004 | 46,400 | 108,949,702,000 | -8,177,694,000 | 3.04 | 8.59 |
Hist
| 06/30/2023 |
Protagonist Therapeutics, Inc
| PTGX | Common | 3,775,900 | 3,775,900 | 104,290,358,000 | 104,290,358,000 | 2.91 | 7.36 |
Hist
| 06/30/2023 |
POINT Biopharma Global Inc.
| PNT | Common | 10,563,748 | 1,386,000 | 95,707,557,000 | 28,801,774,000 | 2.67 | 9.99 |
Hist
| 06/30/2023 |
GALAPAGOS NV
| GLPG | SPON ADR | 2,165,109 | 2,065,109 | 88,033,332,000 | 83,595,332,000 | 2.45 | |
Hist
| 06/30/2023 |
Repare Therapeutics Inc.
| RPTX | Common | 8,291,988 | 0 | 87,729,233,000 | -34,245,910,000 | 2.45 | 19.70 |
Hist
| 06/30/2023 |
4D Molecular Therapeutics, Inc.
| FDMT | Common | 4,007,413 | 0 | 72,413,953,000 | -16,590,690,000 | 2.02 | 12.05 |
Hist
| 06/30/2023 |
Kura Oncology, Inc.
| KURA | Common | 6,730,983 | 2,930,000 | 71,213,800,000 | 24,043,601,000 | 1.98 | 9.84 |
Hist
| 06/30/2023 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 1,827,958 | 556,715 | 70,376,383,000 | 20,251,272,000 | 1.96 | 2.88 |
Hist
| 06/30/2023 |
Olema Pharmaceuticals, Inc.
| OLMA | Common | 7,611,503 | 0 | 68,731,872,000 | 50,083,690,000 | 1.92 | 18.67 |
Hist
| 06/30/2023 |
XOMA Corp
| XOMA | COMMON STOCK | 3,633,743 | 22,249 | 68,641,405,000 | 2,189,915,000 | 1.91 | 31.71 |
Hist
| 06/30/2023 |
Centessa Pharmaceuticals plc
| CNTA | SPONSORED ADS | 9,423,215 | 2,528,870 | 58,329,701,000 | 36,957,231,000 | 1.63 | |
Hist
| 06/30/2023 |
Zymeworks Inc.
| ZYME | Common | 5,870,000 | 0 | 50,716,800,000 | 4,578,600,000 | 1.41 | 9.15 |
Hist
| 06/30/2023 |
Replimune Group, Inc.
| REPL | Common | 2,143,036 | 620,407 | 49,761,296,000 | 8,345,787,000 | 1.39 | 3.71 |
Hist
| 06/30/2023 |
Janux Therapeutics, Inc.
| JANX | Common | 4,106,945 | 2,636,611 | 48,749,437,000 | 29,385,138,000 | 1.36 | 9.82 |
Hist
| 06/30/2023 |
Tyra Biosciences, Inc.
| TYRA | Common | 2,739,595 | 267,268 | 46,655,303,000 | 27,865,618,000 | 1.30 | 6.46 |
Hist
| 06/30/2023 |
LEXICON PHARMACEUTICALS, INC.
| LXRX | COM NEW | 19,995,332 | 3,846,153 | 45,789,310,000 | 14,944,378,000 | 1.28 | 10.59 |
Hist
| 06/30/2023 |
Merus N.V.
| MRUS | COM | 1,602,420 | -1,376,000 | 42,191,719,000 | -3,884,438,000 | 1.18 | |
Hist
| 06/30/2023 |
Relay Therapeutics, Inc.
| RLAY | Stock | 3,120,521 | -755,500 | 39,193,744,000 | -18,714,010,000 | 1.09 | 2.57 |
Hist
| 06/30/2023 |
Allakos Inc.
| ALLK | Common | 8,652,417 | 3,645,496 | 37,724,538,000 | -4,433,737,000 | 1.05 | 10.00 |
Hist
| 06/30/2023 |
89bio, Inc.
| ETNB | Common | 1,846,154 | 1,846,154 | 34,984,618,000 | 34,984,618,000 | 0.98 | |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 3,360,941 | 84,398 | 34,852,958,000 | -16,752,594,000 | 0.97 | 4.76 |
Hist
| 06/30/2023 |
Cullinan Oncology, Inc.
| CGEM | Common | 3,196,701 | -4,312,358 | 34,396,503,000 | -44,824,069,000 | 0.96 | 8.12 |
Hist
| 06/30/2023 |
iTeos Therapeutics, Inc.
| ITOS | Common | 1,810,835 | 0 | 23,975,455,000 | -11,390,153,000 | 0.67 | 5.06 |
Hist
| 06/30/2023 |
ESSA Pharma Inc.
| EPIX | COM NEW | 8,748,629 | 0 | 23,621,298,000 | 1,574,753,000 | 0.66 | 19.84 |
Hist
| 06/30/2023 |
Ovid Therapeutics Inc.
| OVID | COM | 6,851,051 | 0 | 22,471,447,000 | 9,728,492,000 | 0.63 | 9.71 |
Hist
| 06/30/2023 |
AC Immune SA
| ACIU | SHS | 7,428,379 | 0 | 21,950,860,000 | 6,796,967,000 | 0.61 | 8.88 |
Hist
| 06/30/2023 |
Third Harmonic Bio, Inc.
| THRD | Common | 4,365,933 | 0 | 21,000,138,000 | 2,226,626,000 | 0.59 | 10.82 |
Hist
| 06/30/2023 |
Ikena Oncology, Inc.
| IKNA | Common | 3,169,164 | 666,093 | 20,789,716,000 | 14,131,547,000 | 0.58 | 8.74 |
Hist
| 06/30/2023 |
NewAmsterdam Pharma Co N.V.
| NAMS | Common | 1,521,948 | 0 | 18,095,962,000 | 2,085,069,000 | 0.50 | 1.87 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|